Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Oct 17, 2024Oct 18, 2024Fust Matthew K
Dir
SellNeumora Therapeutics, Inc.NMRA$17.03$370,962-52.01%
Mar 20, 2024Mar 22, 2024Fust Matthew K
Dir
SellCrinetics Pharmaceuticals, Inc.CRNX$44.14$3M-76.40%
Mar 07, 2024Mar 11, 2024Fust Matthew K
Dir
SellUltragenyx Pharmaceutical Inc.RARE$50.88$620,443-45.07%
Jul 13, 2022Jul 15, 2022Fust Matthew K
Dir
SellCrinetics Pharmaceuticals, Inc.CRNX$20.96$119,455-31.26%
Nov 04, 2021Nov 05, 2021Fust Matthew K
Dir
SellAtara Biotherapeutics, Inc.ATRA$19.5$260,403-29.77%
Nov 01, 2021Nov 03, 2021Fust Matthew K
Dir
SellCrinetics Pharmaceuticals, Inc.CRNX$25.5$228,327-41.67%
Sep 08, 2021Sep 09, 2021Fust Matthew K
Dir
SellCrinetics Pharmaceuticals, Inc.CRNX$25.5$154,173-32.54%
Jul 26, 2021Jul 28, 2021Fust Matthew K
Dir
SellCrinetics Pharmaceuticals, Inc.CRNX$19.59$97,950-28.51%
Jul 19, 2021Jul 20, 2021Fust Matthew K
Dir
SellCrinetics Pharmaceuticals, Inc.CRNX$19.5$97,500-28.51%
Jul 12, 2021Jul 13, 2021Fust Matthew K
Dir
SellCrinetics Pharmaceuticals, Inc.CRNX$20.71$103,550-28.51%
Jul 06, 2020Jul 08, 2020Fust Matthew K
Dir
SellUltragenyx Pharmaceutical Inc.RARE$90$556,290-31.33%
Jul 01, 2020Jul 06, 2020Fust Matthew K
Dir
SellUltragenyx Pharmaceutical Inc.RARE$85$425,000-26.95%
May 18, 2020May 19, 2020Fust Matthew K
Dir
SellUltragenyx Pharmaceutical Inc.RARE$75$140,625-14.56%
Apr 22, 2020Apr 24, 2020Fust Matthew K
Dir
SellUltragenyx Pharmaceutical Inc.RARE$65$121,875-12.71%
Dec 24, 2019Dec 26, 2019Fust Matthew K
Dir
SellDermira, Inc.DERM$15$45,000-37.26%
Dec 16, 2019Dec 18, 2019Fust Matthew K
Dir
SellCrinetics Pharmaceuticals, Inc.CRNX$22.5$78,750-21.83%
Dec 12, 2019Dec 13, 2019Fust Matthew K
Dir
SellDermira, Inc.DERM$12$36,000-27.15%
Sep 12, 2019Sep 16, 2019Fust Matthew K
Dir
SellDermira, Inc.DERM$8.77$52,636-35.19%
Feb 06, 2019Feb 08, 2019Fust Matthew K
Dir
SellMacrogenics IncMGNX$29.38$203,427-93.27%
Oct 19, 2018Oct 19, 2018Fust Matthew K
Dir
SellDermira, Inc.DERM$13.75$55,000-22.16%
May 30, 2018May 30, 2018Fust Matthew K
Dir
SellUltragenyx Pharmaceutical Inc.RARE$72$454,969-41.93%
May 14, 2018May 17, 2018Fust Matthew K
Dir
SellAtara Biotherapeutics, Inc.ATRA$43.57$535,301-37.64%
Nov 25, 2014Nov 26, 2014Fust Matthew K
Dir
BuyDermira, Inc.DERM$16.77$100,604+50.00%
Jan 30, 2014Feb 04, 2014Fust Matthew K
Dir
BuyUltragenyx Pharmaceutical Inc.RARE$21$105,000+50.00%
Aug 08, 2013Aug 12, 2013Fust Matthew K
EVP
CFO
SellOnyx Pharmaceuticals IncONXX$128.21$319,499-5.82%